Literature DB >> 35228748

Cancer models for reverse and forward translation.

.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35228748     DOI： 10.1038/s43018-022-00346-5

Source DB:  PubMed          Journal:  Nat Cancer        ISSN： 2662-1347


× No keyword cloud information.
  1 in total

1.  Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer.

Authors:  Nancy Gavert; Yaara Zwang; Roi Weiser; Orli Greenberg; Sharon Halperin; Oded Jacobi; Giuseppe Mallel; Oded Sandler; Adi Jacob Berger; Erez Stossel; Daniil Rotin; Albert Grinshpun; Iris Kamer; Jair Bar; Guy Pines; Daniel Saidian; Ilan Bar; Shay Golan; Eli Rosenbaum; Andrei Nadu; Eytan Ben-Ami; Rony Weitzen; Hovav Nechushtan; Talia Golan; Baruch Brenner; Aviram Nissan; Ofer Margalit; Dov Hershkovitz; Guy Lahat; Ravid Straussman
Journal:  Nat Cancer       Date:  2022-02-10
  1 in total
  1 in total

1.  Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data.

Authors:  Natalie C Fisher; Ryan M Byrne; Nigel B Jamieson; Philip D Dunne; Holly Leslie; Colin Wood; Assya Legrini; Andrew J Cameron; Baharak Ahmaderaghi; Shania M Corry; Sudhir B Malla; Raheleh Amirkhah; Aoife J McCooey; Emily Rogan; Keara L Redmond; Svetlana Sakhnevych; Enric Domingo; James Jackson; Maurice B Loughrey; Simon Leedham; Tim Maughan; Mark Lawler; Owen J Sansom; Felicity Lamrock; Viktor H Koelzer
Journal:  Clin Cancer Res       Date:  2022-09-15       Impact factor: 13.801
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.